Regulation of Body Composition and Bioenergetics by Estrogens

Endocrinology and Metabolism Clinics of North America

Volumn 44, Issue 3, 2015, Pages 663-676

  Van Pelt, Rachael E ^a   Gavin, Kathleen M ^a   Kohrt, Wendy M ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Adiposity; Body composition; Energy expenditure; Energy intake; Estradiol; Estrogen receptor; Menopause; Ovariectomy

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; GESTAGEN; GONADORELIN AGONIST; PLACEBO;

ABDOMINAL FAT; ABDOMINAL OBESITY; BIOENERGY; BODY COMPOSITION; BODY FAT DISTRIBUTION; CALORIC INTAKE; ENERGY BALANCE; ENERGY EXPENDITURE; ESTROGEN THERAPY; GLUCOSE INTOLERANCE; HUMAN; INSULIN RESISTANCE; LIPID STORAGE; NONHUMAN; PHYSICAL ACTIVITY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; RESTING METABOLIC RATE; REVIEW; WAIST CIRCUMFERENCE; ENERGY METABOLISM; FEMALE; MENOPAUSE; METABOLISM; PHYSIOLOGY;

BODY COMPOSITION; ENERGY METABOLISM; ESTROGENS; FEMALE; HUMANS; MENOPAUSE;

EID: 84940453777     PISSN: 08898529     EISSN: 15584410     Source Type: Journal    
DOI: 10.1016/j.ecl.2015.05.011     Document Type: Review

References (70)

1. Gruber C.J., Tschugguel W., Schneeberger C., et al. Production and actions of estrogens. N Engl J Med 2002, 346(5):340-352.
2. Rettberg J.R., Yao J., Brinton R.D. Estrogen: a master regulator of bioenergetic systems in the brain and body. Front Neuroendocrinol 2014, 35(1):8-30.
3. Yang S.H., Liu R., Perez E.J., et al. Mitochondrial localization of estrogen receptor beta. Proc Natl Acad Sci U S A 2004, 101(12):4130-4135.
4. Jensen E.V. On the mechanism of estrogen action. Perspect Biol Med 1962, 6:47-59.
5. Kuiper G.G., Enmark E., Pelto-Huikko M., et al. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A 1996, 93(12):5925-5930.
6. Pappas T.C., Gametchu B., Watson C.S. Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding. FASEB J 1995, 9(5):404-410.
7. O'Malley B.W., Tsai M.J. Molecular pathways of steroid receptor action. Biol Reprod 1992, 46(2):163-167.
8. Sutter-Dub M.T. Rapid non-genomic and genomic responses to progestogens, estrogens, and glucocorticoids in the endocrine pancreatic B cell, the adipocyte and other cell types. Steroids 2002, 67(2):77-93.
9. Kuiper G.G., Carlsson B., Grandien K., et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997, 138(3):863-870.
10. Paech K., Webb P., Kuiper G.G., et al. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 1997, 277(5331):1508-1510.
11. Dieudonne M.N., Leneveu M.C., Guidicelli Y., et al. Evidence for functional estrogen receptors α and β in human adipose cells: regional specificities and regulation by estrogens. Am J Physiol Cell Physiol 2004, 286:655-661.
12. Barros R.P., Gabbi C., Morani A., et al. Participation of ERalpha and ERbeta in glucose homeostasis in skeletal muscle and white adipose tissue. Am J Physiol Endocrinol Metab 2009, 297(1):E124-E133.
13. Sakaguchi H., Fujimoto J., Aoki I., et al. Expression of estrogen receptor alpha and beta in myometrium of premenopausal and postmenopausal women. Steroids 2003, 68(1):11-19.
14. Gavin K.M., Cooper E.E., Hickner R.C. Estrogen receptor protein content is different in abdominal than gluteal subcutaneous adipose tissue of overweight-to-obese premenopausal women. Metabolism 2013, 62(8):1180-1188.
15. Wend K., Wend P., Krum S.A. Tissue-specific effects of loss of estrogen during menopause and aging. Front Endocrinol (Lausanne) 2012, 3:19.
16. Lubahn D.B., Moyer J.S., Golding T.S., et al. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci U S A 1993, 90(23):11162-11166.
17. Krege J.H., Hodgin J.B., Couse J.F., et al. Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci U S A 1998, 95(26):15677-15682.
18. Musatov S., Chen W., Pfaff D.W., et al. Silencing of estrogen receptor alpha in the ventromedial nucleus of hypothalamus leads to metabolic syndrome. Proc Natl Acad Sci U S A 2007, 104(7):2501-2506.
19. Ribas V., Drew B.G., Le J.A., et al. Myeloid-specific estrogen receptor alpha deficiency impairs metabolic homeostasis and accelerates atherosclerotic lesion development. Proc Natl Acad Sci U S A 2011, 108(39):16457-16462.
20. Xu Y., Nedungadi T.P., Zhu L., et al. Distinct hypothalamic neurons mediate estrogenic effects on energy homeostasis and reproduction. Cell Metab 2011, 14(4):453-465.
21. Park C.J., Zhao Z., Glidewell-Kenney C., et al. Genetic rescue of nonclassical ERalpha signaling normalizes energy balance in obese ERalpha-null mutant mice. J Clin Invest 2011, 121(2):604-612.
22. Pedram A., Razandi M., Kim J.K., et al. Developmental phenotype of a membrane only estrogen receptor alpha (MOER) mouse. J Biol Chem 2009, 284(6):3488-3495.
23. Syed F.A., Fraser D.G., Monroe D.G., et al. Distinct effects of loss of classical estrogen receptor signaling versus complete deletion of estrogen receptor alpha on bone. Bone 2011, 49(2):208-216.
24. Heine P.A., Taylor J.A., Iwamoto G.A., et al. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci U S A 2000, 97(23):12729-12734.
25. Naaz A., Zakroczymski M., Heine P., et al. Effect of ovariectomy on adipose tissue of mice in the absence of estrogen receptor alpha (ERalpha): a potential role for estrogen receptor beta (ERbeta). Horm Metab Res 2002, 34(11-12):758-763.
26. Lindberg M.K., Weihua Z., Andersson N., et al. Estrogen receptor specificity for the effects of estrogen in ovariectomized mice. J Endocrinol 2002, 174(2):167-178.
27. Seidlova-Wuttke D., Nguyen B.T., Wuttke W. Long-term effects of ovariectomy on osteoporosis and obesity in estrogen-receptor-beta-deleted mice. Comp Med 2012, 62(1):8-13.
28. Jones M.E., Thorburn A.W., Britt K.L., et al. Aromatase-deficient (ArKO) mice accumulate excess adipose tissue. J Steroid Biochem Mol Biol 2001, 79(1-5):3-9.
29. Revankar C.M., Cimino D.F., Sklar L.A., et al. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 2005, 307(5715):1625-1630.
30. Thomas P., Pang Y., Filardo E.J., et al. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 2005, 146(2):624-632.
31. Davis K.E., Carstens E.J., Irani B.G., et al. Sexually dimorphic role of G protein-coupled estrogen receptor (GPER) in modulating energy homeostasis. Horm Behav 2014, 66(1):196-207.
32. Isensee J., Meoli L., Zazzu V., et al. Expression pattern of G protein-coupled receptor 30 in LacZ reporter mice. Endocrinology 2009, 150(4):1722-1730.
33. Ogawa S., Chan J., Gustafsson J.A., et al. Estrogen increases locomotor activity in mice through estrogen receptor alpha: specificity for the type of activity. Endocrinology 2003, 144(1):230-239.
34. Geary N., Asarian L., Korach K.S., et al. Deficits in E2-dependent control of feeding, weight gain, and cholecystokinin satiation in ER-alpha null mice. Endocrinology 2001, 142(11):4751-4757.
35. Foryst-Ludwig A., Clemenz M., Hohmann S., et al. Metabolic actions of estrogen receptor beta (ERbeta) are mediated by a negative cross-talk with PPARgamma. PLoS Genet 2008, 4(6):e1000108.
36. Spiteri T., Ogawa S., Musatov S., et al. The role of the estrogen receptor alpha in the medial preoptic area in sexual incentive motivation, proceptivity and receptivity, anxiety, and wheel running in female rats. Behav Brain Res 2012, 230(1):11-20.
37. Felicio L.S., Nelson J.F., Finch C.E. Longitudinal studies of estrous cyclicity in aging C57BL/6J mice: II. Cessation of cyclicity and the duration of persistent vaginal cornification. Biol Reprod 1984, 31(3):446-453.
38. Durbin P.W., Williams M.H., Jeung N., et al. Development of spontaneous mammary tumors over the life-span of the female Charles River (Sprague-Dawley) rat: the influence of ovariectomy, thyroidectomy, and adrenalectomy-ovariectomy. Cancer Res 1966, 26(3):400-411.
39. Rogers N.H., Perfield J.W., Strissel K.J., et al. Reduced energy expenditure and increased inflammation are early events in the development of ovariectomy-induced obesity. Endocrinology 2009, 150(5):2161-2168.
40. Witte M.M., Resuehr D., Chandler A.R., et al. Female mice and rats exhibit species-specific metabolic and behavioral responses to ovariectomy. Gen Comp Endocrinol 2010, 166(3):520-528.
41. Gloy V., Langhans W., Hillebrand J.J., et al. Ovariectomy and overeating palatable, energy-dense food increase subcutaneous adipose tissue more than intra-abdominal adipose tissue in rats. Biol Sex Differ 2011, 2:6.
42. Jackson K.C., Wohlers L.M., Lovering R.M., et al. Ectopic lipid deposition and the metabolic profile of skeletal muscle in ovariectomized mice. Am J Physiol Regul Integr Comp Physiol 2013, 304(3):R206-R217.
43. Yonezawa R., Wada T., Matsumoto N., et al. Central versus peripheral impact of estradiol on the impaired glucose metabolism in ovariectomized mice on a high-fat diet. Am J Physiol Endocrinol Metab 2012, 303(4):E445-E456.
44. Fu Y., Li R., Zhong J., et al. Adipogenic differentiation potential of adipose-derived mesenchymal stem cells from ovariectomized mice. Cell Prolif 2014, 47(6):604-614.
45. Gorzek J.F., Hendrickson K.C., Forstner J.P., et al. Estradiol and tamoxifen reverse ovariectomy-induced physical inactivity in mice. Med Sci Sports Exerc 2007, 39(2):248-256.
46. Ferreira J.A., Foley A.M., Brown M. Sex hormones differentially influence voluntary running activity, food intake and body weight in aging female and male rats. Eur J Appl Physiol 2012, 112(8):3007-3018.
47. Stubbins R.E., Holcomb V.B., Hong J., et al. Estrogen modulates abdominal adiposity and protects female mice from obesity and impaired glucose tolerance. Eur J Nutr 2012, 51(7):861-870.
48. Wright L.E., Christian P.J., Rivera Z., et al. Comparison of skeletal effects of ovariectomy versus chemically induced ovarian failure in mice. J Bone Miner Res 2008, 23(8):1296-1303.
49. Roth C.L., Neu C., Jarry H., et al. Different effects of agonistic vs. antagonistic GnRH-analogues (triptorelin vs. cetrorelix) on bone modeling and remodeling in peripubertal female rats. Exp Clin Endocrinol Diabetes 2005, 113(8):451-456.
50. Camporez J.P., Jornayvaz F.R., Lee H.Y., et al. Cellular mechanism by which estradiol protects female ovariectomized mice from high-fat diet-induced hepatic and muscle insulin resistance. Endocrinology 2013, 154(3):1021-1028.
51. Asarian L., Geary N. Cyclic estradiol treatment normalizes body weight and restores physiological patterns of spontaneous feeding and sexual receptivity in ovariectomized rats. Horm Behav 2002, 42(4):461-471.
52. Hertrampf T., Degen G.H., Kaid A.A., et al. Combined effects of physical activity, dietary isoflavones and 17beta-estradiol on movement drive, body weight and bone mineral density in ovariectomized female rats. Planta Med 2006, 72(6):484-487.
53. Hertrampf T., Seibel J., Laudenbach U., et al. Analysis of the effects of oestrogen receptor alpha (ERalpha)- and ERbeta-selective ligands given in combination to ovariectomized rats. Br J Pharmacol 2008, 153(7):1432-1437.
54. Espeland M.A., Stefanick M.L., Kritz-Silverstein D., et al. Effect of postmenopausal hormone therapy on body weight and waist and hip girths. Postmenopausal estrogen-progestin interventions study investigators. J Clin Endocrinol Metab 1997, 82(5):1549-1556.
55. Utian W.H., Gass M.L., Pickar J.H. Body mass index does not influence response to treatment, nor does body weight change with lower doses of conjugated estrogens and medroxyprogesterone acetate in early postmenopausal women. Menopause 2004, 11(3):306-314.
56. Chen Z., Bassford T., Green S.B., et al. Postmenopausal hormone therapy and body composition-a substudy of the estrogen plus progestin trial of the women's health initiative. Am J Clin Nutr 2005, 82(3):651-656.
57. Jensen L.B., Vestergaard P., Hermann A.P., et al. Hormone replacement therapy dissociates fat mass and bone mass, and tends to reduce weight gain in early postmenopausal women: a randomized controlled 5-year clinical trial of the Danish Osteoporosis Prevention Study. J Bone Miner Res 2003, 18(2):333-342.
58. Salpeter S.R., Walsh J.M., Ormiston T.M., et al. Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Diabetes Obes Metab 2006, 8(5):538-554.
59. Van Pelt R.E., Gozansky W.S., Schwartz R.S., et al. Intravenous estrogens increase insulin clearance and action in postmenopausal women. Am J Physiol Endocrinol Metab 2003, 285(2):E311-E317.
60. Van Pelt R.E., Schwartz R.S., Kohrt W.M. Insulin secretion and clearance after subacute estradiol administration in postmenopausal women. J Clin Endocrinol Metab 2008, 93(2):484-490.
61. Nowicki M., Adamkiewicz G., Bryc W., et al. The influence of luteinizing hormone-releasing hormone analog on serum leptin and body composition in women with solitary uterine myoma. Am J Obstet Gynecol 2002, 186(3):340-344.
62. Yamasaki H., Douchi T., Yamamoto S., et al. Body fat distribution and body composition during GnRH agonist therapy. Obstet Gynecol 2001, 97(3):338-342.
63. Douchi T., Kuwahata R., Yamasaki H., et al. Inverse relationship between the changes in trunk lean and fat mass during gonadotropin-releasing hormone agonist therapy. Maturitas 2002, 42(1):31-35.
64. Douchi T., Kuwahata T., Yoshimitsu N., et al. Changes in serum leptin levels during GnRH agonist therapy. Endocr J 2003, 50(3):355-359.
65. Shea K.L., Gavin K.M., Melanson E.L., et al. Body composition and bone mineral density after ovarian hormone suppression with or without estradiol treatment. Menopause 2015, [Epub ahead of print].
66. Revilla R., Revilla M., Villa L.F., et al. Changes in body composition in women treated with gonadotropin-releasing hormone agonists. Maturitas 1998, 31(1):63-68.
67. Day D.S., Gozansky W.S., Van Pelt R.E., et al. Sex hormone suppression reduces resting energy expenditure and {beta}-adrenergic support of resting energy expenditure. J Clin Endocrinol Metab 2005, 90(6):3312-3317.
68. Anderson E.J., Lavoie H.B., Strauss C.C., et al. Body composition and energy balance: lack of effect of short-term hormone replacement in postmenopausal women. Metabolism 2001, 50(3):265-269.
69. Bessesen D.H., Cox-York K.A., Hernandez T.L., et al. Postprandial triglycerides and adipose tissue storage of dietary fatty acids: impact of menopause and estradiol. Obesity (Silver Spring) 2015, 23(1):145-153.
70. Lovejoy J.C., Champagne C.M., de Jonge L., et al. Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes 2008, 32(6):949-958.